{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:49:19Z","timestamp":1781070559530,"version":"3.54.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:p>Multiple myeloma (MM) is a heterogeneous hematologic malignancy characterized by high recurrence rates and incurability despite therapeutic advances. Emerging evidence implicates circulating inflammatory proteins, plasma metabolites, and leukocyte characteristics in MM pathogenesis, though their specific causal roles remain unclear. To investigate these relationships, we employed a 2-sample Mendelian randomization approach using genome-wide association study data. Genetic variants served as instrumental variables for biomarkers and MM outcomes. Our analysis identified 4 circulating inflammatory proteins with suggestive causal associations to MM and implicated 50 plasma metabolites in MM risk. However, no clear causal links were found between leukocyte characteristics and MM. Mediation analysis further revealed that the effects of inflammatory proteins on MM risk were not mediated by plasma metabolites. Collectively, these findings provide evidence for potential causal roles of specific inflammatory proteins and metabolites in MM, offering new insights into its biological mechanisms.<\/jats:p>","DOI":"10.1097\/md.0000000000043315","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:01:22Z","timestamp":1752516082000},"page":"e43315","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Causal insights into multiple myeloma: The impact of circulating inflammatory proteins and metabolites"],"prefix":"10.1097","volume":"104","author":[{"given":"Pengfei","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoying","family":"Li","sequence":"additional","affiliation":[{"name":"School of Queen Mary, Jiangxi Medical College, Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7668-8495","authenticated-orcid":false,"given":"Hao","family":"Sha","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China"},{"name":"School of Queen Mary, Jiangxi Medical College, Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3324\/haematol.2013.090977","article-title":"Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.","volume":"99","author":"Noll","year":"2014","journal-title":"Haematologica"},{"issue":"Supplement 1","key":"R2-20250812","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2020-138819","article-title":"Bone pain as a presenting symptom in patients with newly diagnosed multiple myeloma in the primary care setting: a population-based cohort study.","volume":"136","author":"Seesaghur","year":"2020","journal-title":"Blood"},{"key":"R3-20250812","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1634\/theoncologist.2016-0104","article-title":"Analysis of real-world data on overall survival in multiple myeloma patients with \u22653 prior lines of therapy including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or double refractory to a PI and an IMiD.","volume":"21","author":"Usmani","year":"2016","journal-title":"Oncologist"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ccell.2018.02.007","article-title":"Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment.","volume":"33","author":"Nakamura","year":"2018","journal-title":"Cancer Cell"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"e0202045","DOI":"10.1371\/journal.pone.0202045","article-title":"The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets.","volume":"13","author":"Steiner","year":"2018","journal-title":"PLoS One"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-021-22804-x","article-title":"Co-evolution of tumor and immune cells during progression of multiple myeloma.","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2003.04561.x","article-title":"Serum levels of macrophage inflammatory protein-1 alpha (MIP-1\u03b1) correlate with the extent of bone disease and survival in patients with multiple myeloma.","volume":"123","author":"Terpos","year":"2003","journal-title":"Br J Haematol"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"155358","DOI":"10.1016\/j.cyto.2020.155358","article-title":"Cytokine profiles in patients with newly diagnosed multiple myeloma: survival is associated with IL-6 and IL-17A levels.","volume":"138","author":"Gu","year":"2021","journal-title":"Cytokine"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00281-016-0597-6","article-title":"Myeloid-derived suppressor cells and tumor escape from immune surveillance.","volume":"39","author":"Umansky","year":"2017","journal-title":"Semin Immunopathol"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/gm333","article-title":"Genome-wide association studies with metabolomics.","volume":"4","author":"Adamski","year":"2012","journal-title":"Genome Med"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0036-1585406","article-title":"An introduction to genome-wide association studies: GWAS for dummies.","volume":"34","author":"Uitterlinden","year":"2016","journal-title":"Semin Reprod Med"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","article-title":"Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations.","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2010","journal-title":"Int J Epidemiol"},{"key":"R18-20250812","first-page":"629","article-title":"One hundred years of linkage disequilibrium.","volume":"209","author":"Sved","year":"2018","journal-title":"Genetics"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.","volume":"45","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies.","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R24-20250812","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"R25-20250812","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"237","DOI":"10.15430\/JCP.2021.26.4.237","article-title":"Role of branched-chain amino acid metabolism in tumor development and progression.","volume":"26","author":"Jung","year":"2021","journal-title":"J Cancer Prev"},{"key":"R27-20250812","doi-asserted-by":"crossref","first-page":"105038","DOI":"10.1016\/j.tiv.2020.105038","article-title":"Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells.","volume":"70","author":"Fouzder","year":"2021","journal-title":"Toxicol In Vitro"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1158\/0008-5472.CAN-19-2567","article-title":"A prospective analysis of circulating plasma metabolites associated with ovarian cancer risk.","volume":"80","author":"Zeleznik","year":"2020","journal-title":"Cancer Res"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12291-011-0175-6","article-title":"Inflammation and the metabolic syndrome.","volume":"26","author":"Sharma","year":"2011","journal-title":"Indian J Clin Biochem"},{"key":"R30-20250812","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1748-1716.2007.01779.x","article-title":"Role of interleukin-6 signalling in glucose and lipid metabolism.","volume":"192","author":"Glund","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"R31-20250812","doi-asserted-by":"crossref","first-page":"30527","DOI":"10.1074\/jbc.M008481200","article-title":"Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-\u03b1- and interleukin-1\u03b2-induced NF-\u03baB activation.","volume":"276","author":"Anthonsen","year":"2001","journal-title":"J Biol Chem"},{"key":"R32-20250812","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n\u22123 Polyunsaturated fatty acids, inflammation, and inflammatory diseases 2.","volume":"83","author":"Calder","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R34-20250812","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10555-007-9098-3","article-title":"Lipoxygenase metabolism: roles in tumor progression and survival.","volume":"26","author":"Pidgeon","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"R35-20250812","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.027","article-title":"Mutual regulation of metabolic processes and proinflammatory NF-\u03baB signaling.","volume":"146","author":"Kracht","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R36-20250812","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response.","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:00:45Z","timestamp":1755018045000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":35,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043315","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}